What Are Peptides? A Complete Beginner's Guide
Peptides are among the most fundamental molecules in biology — yet for most people, they remain abstract. This guide covers what peptides are at a structural level, how they differ from proteins, what they do naturally in the body, and why they've become one of the most active areas in pharmaceutical and research science.
This article is written for educational purposes. It covers the science of peptides as understood through published research. Nothing here constitutes medical advice or a recommendation for personal use of any compound.
The Definition: What Is a Peptide?
A peptide is a short chain of amino acids linked together by peptide bonds — the covalent bonds formed between the carboxyl group of one amino acid and the amino group of the next. The term "peptide" generally refers to chains of fewer than 50 amino acids. Chains of 50 or more amino acids are typically called proteins, though this boundary is not rigidly defined and is more a convention than a sharp biochemical distinction.
Amino acids are the building blocks of both peptides and proteins. There are 20 standard amino acids encoded by the human genome, and the specific sequence in which they're arranged determines the structure, shape, and function of the resulting peptide. A change in even a single amino acid — a mutation or deliberate modification — can dramatically alter a peptide's behavior.
The term "polypeptide" is sometimes used for longer chains that aren't yet folded into a functional protein. In practice, "peptide," "polypeptide," and "protein" exist on a continuum rather than as rigidly separate categories.
Peptides vs Proteins: What's the Difference?
The distinction between peptides and proteins is primarily one of size and structural complexity. Proteins fold into intricate three-dimensional shapes that are central to their function — enzymes, receptors, antibodies. Peptides, being shorter, generally don't achieve the same degree of complex folding, though they can still adopt secondary structures like alpha-helices and beta-sheets.
| Property | Peptide | Protein |
|---|---|---|
| Size | 2–50 amino acids | 50+ amino acids (often hundreds to thousands) |
| Structure | Usually linear; may be cyclic | Complex 3D folded structures (secondary, tertiary, quaternary) |
| Molecular Weight | < 10 kDa typically | > 10 kDa |
| Stability | Lower — more susceptible to enzymatic degradation | Variable — depends on folding |
| Oral Bioavailability | Generally poor; most require injection or alternative routes | Also poor for therapeutic use; digested in GI tract |
| Synthesis | Can be chemically synthesized (SPPS) | Typically biosynthetic (recombinant expression) |
From a research and therapeutic perspective, peptides offer several practical advantages: they can often be synthesized chemically with high precision, they tend to interact with specific biological targets, and modifications to their amino acid sequence can be used to tune their activity, selectivity, or stability in ways that are difficult to achieve with small molecules or large proteins.
How Peptides Are Made
In the body, peptides are synthesized by ribosomes following instructions encoded in messenger RNA (mRNA), which is itself transcribed from DNA. A ribosome reads the mRNA codon by codon, assembling the corresponding amino acids into a growing peptide chain.
In laboratory and pharmaceutical settings, peptides are most commonly produced via solid-phase peptide synthesis (SPPS) — a technique developed by Robert Bruce Merrifield in the 1960s, for which he received the Nobel Prize in Chemistry in 1984. SPPS builds a peptide chain amino acid by amino acid on a solid support bead, allowing for precise sequence control. Modern automated SPPS systems can synthesize peptides of 30–50 amino acids with high purity.
Longer or more complex peptides — particularly those requiring post-translational modifications — may be produced through recombinant expression in bacterial, yeast, or mammalian cell systems, similar to how proteins are produced. Insulin, for example, is now produced recombinantly in E. coli or Saccharomyces cerevisiae rather than extracted from animal pancreases.
Peptides the Body Already Makes
The human body produces thousands of endogenous peptides that regulate virtually every physiological system. Many of the most important hormones are peptides. The following are among the most studied:
Insulin
Glucose uptake regulation; produced by pancreatic beta cells
Glucagon
Raises blood glucose when levels drop; counteracts insulin
Oxytocin
Social bonding, uterine contraction, and lactation
Vasopressin (ADH)
Water reabsorption in kidneys; blood pressure regulation
GnRH
Triggers release of LH and FSH from the pituitary
Ghrelin
Hunger signaling; GH secretagogue produced in the stomach
BPC (Body Protection Compound)
Endogenous gastric protein with cytoprotective properties
Thymosin Beta-4
Actin sequestration; wound healing and tissue remodeling
IGF-1
Mediates many of GH's effects; promotes cell growth and division
GHRH
Hypothalamic hormone that stimulates GH release from pituitary
The fact that many research peptides are synthetic versions or analogs of endogenous compounds is significant: the body already has receptors and signaling pathways designed to respond to peptide signals. Synthetic peptides often work by mimicking, amplifying, or modulating these existing systems rather than introducing entirely foreign mechanisms.
Major Categories of Research Peptides
The peptide research landscape is broad. Below are the primary functional categories, with representative compounds and the mechanisms being studied. Note that regulatory status varies significantly — some of these have FDA approval for specific indications; many are strictly research-phase compounds.
Ipamorelin, GHRP-6, Hexarelin
Bind ghrelin receptors in the pituitary to trigger release of endogenous growth hormone in a pulsatile pattern. Used in research contexts involving body composition, recovery, and aging.
CJC-1295, Tesamorelin, Sermorelin
Synthetic analogs of endogenous GHRH. Stimulate the GHRH receptor in the anterior pituitary to amplify GH production and release. Often stacked with GHRPs for synergistic effect.
BPC-157, TB-500 (Thymosin Beta-4), GHK-Cu
Involved in wound healing, angiogenesis, collagen synthesis, and anti-inflammatory signaling. BPC-157 in particular has been studied extensively in animal models of gastrointestinal and musculoskeletal injury.
Semaglutide, Tirzepatide, Retatrutide, AOD-9604
Peptide hormones (or analogs) that regulate insulin secretion, appetite, gastric emptying, and energy metabolism. GLP-1 agonists have become among the most clinically significant peptide drugs in modern medicine.
Semax, Selank, Dihexa, Cerebrolysin, Epithalon
Peptides studied for neurogenesis, BDNF upregulation, neuroprotection, anxiolysis, and cognitive enhancement. Many originate from Soviet-era neuroscience research and have significant preclinical evidence.
Defensins, Magainins, LL-37
Part of the innate immune system. Disrupt bacterial membranes through physical mechanisms rather than target-specific binding, making resistance development more difficult. A major area of antibiotic research.
Insulin, Oxytocin, Vasopressin, GnRH analogs
Many endogenous hormones are peptides. Insulin is the most clinically familiar — a 51-amino acid peptide essential to glucose metabolism. Synthetic versions and analogs of hormonal peptides are extensively used in medicine.
PT-141 (Bremelanotide), Melanotan II, α-MSH
Act on melanocortin receptors involved in pigmentation, sexual function, appetite, and inflammation. PT-141 has clinical approval for hypoactive sexual desire disorder in women.
How Peptides Are Delivered
One of the central challenges in peptide therapeutics is delivery. Because peptides are composed of amino acids, they are recognized by the body's digestive enzymes and broken down in the gastrointestinal tract — which is why most therapeutic peptides cannot simply be taken orally as pills. Several delivery strategies are used in research and clinical contexts:
Subcutaneous Injection
The most common route for research peptides. A small needle deposits the peptide into the layer of fat beneath the skin, where it is gradually absorbed into the bloodstream. Offers reliable bioavailability and avoids first-pass hepatic metabolism.
Intramuscular Injection
Directly into muscle tissue. Faster absorption than subcutaneous in some cases. Used for certain peptides where depot-style slow release isn't needed.
Intranasal (Nasal Spray)
Peptides administered nasally can absorb through the nasal mucosa and, for some compounds, access the central nervous system more directly via the olfactory pathway. Used for CNS-targeted peptides like Semax, Selank, and PT-141. Bioavailability is lower than injection but sufficient for many applications.
Oral (Pills or Sublingual)
Historically poor for peptides due to enzymatic degradation. However, advances in encapsulation, modification chemistry, and lipid nanoparticles are improving oral delivery. Semaglutide is now available in oral form (Rybelsus) through specific modification and formulation strategies. A major area of pharmaceutical innovation.
Transdermal
Peptides applied to skin can penetrate the dermal barrier with the right penetration enhancers or formulation chemistry. Used for some cosmetic peptides (e.g., GHK-Cu in skincare) and being researched for therapeutic peptides.
Intravenous (IV)
Direct bloodstream delivery — used primarily in clinical settings. Provides immediate bioavailability but requires sterile administration conditions and is not practical for outpatient research protocols.
Key Areas of Peptide Research
Peptides are among the fastest-growing areas in pharmaceutical development. The following are active research domains with significant published literature:
Metabolic Disease
GLP-1 receptor agonists (semaglutide, tirzepatide) have become first-line treatments for type 2 diabetes and obesity, validated through large-scale randomized controlled trials. The mechanism — slowing gastric emptying, increasing insulin secretion, and reducing appetite — is now among the most well-understood in metabolic pharmacology.
Musculoskeletal & Soft Tissue Repair
BPC-157 has demonstrated cytoprotective and regenerative effects across a broad range of animal models, including tendon-to-bone healing, gut epithelium repair, and nerve regeneration. TB-500's active fragment (Ac-SDKP) promotes angiogenesis and actin dynamics relevant to wound healing. Neither has completed clinical trials in humans.
Growth Hormone Axis
GHRH analogs and GHRPs are studied for their effects on GH secretion, IGF-1 levels, body composition, and recovery. Tesamorelin is FDA-approved. Sermorelin was historically prescribed in anti-aging contexts. Ipamorelin and CJC-1295 remain in research phases but have extensive off-label use documentation.
Neuroscience & Cognition
Peptides cross the blood-brain barrier less readily than small molecules, but several — particularly Semax, Selank, and Dihexa — have demonstrated CNS activity via intranasal routes. Semax is an ACTH analog with neuroprotective and cognitive effects studied in ischemic stroke and attention research in Russia.
Antimicrobial Resistance
With bacterial resistance to conventional antibiotics escalating globally, antimicrobial peptides (AMPs) are intensively researched as alternatives. Their membrane-disrupting mechanism is structurally harder for bacteria to evolve resistance against. Multiple AMPs are in clinical trials.
Cancer Biology
Peptides are investigated both as cancer therapeutics (targeting specific tumor receptors) and as diagnostic imaging agents. Radiolabeled peptides targeting somatostatin receptors (like octreotide) are clinically used in neuroendocrine tumor diagnosis and treatment.
Limitations and Regulatory Context
Understanding peptides requires an honest account of their limitations and the regulatory landscape surrounding them.
Most research peptides are not FDA-approved
Outside of specific clinical applications (insulin, GLP-1 agonists, Tesamorelin, Bremelanotide, etc.), the majority of commonly researched peptides have not completed clinical trials and are not approved for human use. The research literature, which is frequently cited by enthusiasts, is largely preclinical — meaning animal studies or in vitro experiments.
Animal models don't always translate to humans
Many peptides show striking effects in rodent models. BPC-157 is a well-documented example: impressive gastrointestinal, tendon, and neurological effects in rats. Human clinical trials are sparse. The gap between animal data and validated human outcomes is a serious limitation that is often underrepresented in community discussions.
Purity and sourcing quality varies widely
Research peptides sold outside pharmaceutical channels vary significantly in purity, concentration accuracy, and sterility. Third-party certificate of analysis (COA) testing is the minimum standard for quality verification. Contaminated or mislabeled products represent a non-trivial risk.
Long-term safety data is limited
Even for peptides with reasonable short-term safety profiles, long-term data in humans is generally absent. Chronic modulation of GH, IGF-1, or other signaling axes over years is not well-characterized.
Regulatory classification differs by country
In the United States, many research peptides occupy a gray area — not scheduled controlled substances, but not approved for human use either. The FDA has issued warnings about specific compounds sold as dietary supplements. Regulations in Canada, the EU, Australia, and the UK vary. Researchers should understand the legal status in their jurisdiction.
Continue Your Research
Peptide Database
Detailed profiles for 51+ research peptides — mechanisms, uses, dosing, and research status.
Peptide Dosing Guide
Beginner to advanced protocol reference — dosing charts for injectable and nasal peptides.
Reconstitution Guide
Step-by-step instructions for mixing lyophilized peptides correctly, with dosing math.
Frequently Asked Questions
Common questions about peptide research answered directly and without jargon.
Step 2 of 8
Do Peptides Work?
Other Articles
Calculator
Calculate exact reconstitution volumes and insulin unit doses for any peptide protocol.
Open Calculator →
